Issue 2/2020
Content (7 Articles)
Correlation between IDH, ATRX, and TERT promoter mutations in glioma
Shigeo Ohba, Kiyonori Kuwahara, Seiji Yamada, Masato Abe, Yuichi Hirose
Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells
Tsubasa Miyazaki, Eiichi Ishikawa, Masahide Matsuda, Narushi Sugii, Hedihiro Kohzuki, Hiroyoshi Akutsu, Noriaki Sakamoto, Shingo Takano, Akira Matsumura
Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort
Junya Fukai, Hideyuki Arita, Toru Umehara, Ema Yoshioka, Tomoko Shofuda, Daisuke Kanematsu, Yoshinori Kodama, Masayuki Mano, Manabu Kinoshita, Yoshiko Okita, Masahiro Nonaka, Takehiro Uda, Naohiro Tsuyuguchi, Daisuke Sakamoto, Yuji Uematsu, Naoyuki Nakao, Kanji Mori, Yonehiro Kanemura
Placental alkaline phosphatase in cerebrospinal fluid as a biomarker for optimizing surgical treatment strategies for pineal region germ cell tumors
Kentaro Chiba, Yasuo Aihara, Takashi Komori, Takakazu Kawamata
Malignant transformation of a dysembryoplastic neuroepithelial tumor verified by a shared copy number gain of the tyrosine kinase domain of FGFR1
Nozomi Matsumura, Atsushi Natsume, Sachi Maeda, Kosuke Aoki, Tatsuya Yamazaki, Sumihito Nobusawa, Hideaki Yokoo
Intracranial myxoid mesenchymal tumor with EWSR1–CREB1 gene fusion: a case report and literature review
Masato Komatsu, Akihiko Yoshida, Kazuhiro Tanaka, Kazuya Matsuo, Takashi Sasayama, Yasuyuki Kojita, Tomonori Kanda, Yoshinori Kodama, Tomoo Itoh, Takanori Hirose